Many men feel overwhelmed by options when deciding how to treat their prostate cancer. To educate community members on this complex topic, Huntsman Cancer Institute joined our affiliate hospital St. John's Medical Center at the 2018 Cancer Summit to discuss advances in prostate cancer diagnosis and care.
"prostate cancer" News
African American men experience significant health disparities. They are almost twice as likely to be diagnosed with prostate cancer as white men, yet they are underrepresented in prostate cancer research. A new study by Charles R. Rogers, PhD, MPH, MS, CHES®, uncovers attitudes toward prostate cancer research among African American men and suggests strategies to increase participation in research. The study is included in a new collection of research on health disparities impacting African American men.
Tommy Tanzer, a resident of Park City, Utah, received three negative prostate biopsies over the course of three years, but he and his doctors still suspected he may have cancer. Tommy then had an MRI-guided biopsy at Huntsman Cancer Institute (HCI), hoping there would be a more accurate result. Unfortunately, this biopsy did detect cancer. Fortunately, it was found early enough to treat.
Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.
Jonathan Tward, MD, PhD, explains how he began his career as a radiation oncologist, what he's learned from his patients, and why he loves an unusual sport.
Choosing the right treatment after being diagnosed with prostate cancer can seem overwhelming. Here are some things to consider as you work with your doctor to choose the best option.
Huntsman Cancer Institute researcher Andrew Hahn, MD, received the Conquer Cancer Foundation of ASCO Merit Award. The award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.